World’s most comprehensive manufacturer of health care products selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, September 28, 2007 – clinivation, Inc. announced today that Johnson & Johnson (NYSE: JNJ) has selected clinivation WorldView® Online Regulatory Intelligence web service.
“We are pleased that Johnson & Johnson has selected clinivation WorldView as their most comprehensive, authoritative, and up-to-date resource for regulatory intelligence,” remarked
Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “With clear, step-by-step registration processes for >99% of the world markets, Johnson & Johnson will have access to important regulatory and compliance information in one centralized place,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Johnson & Johnson
Johnson & Johnson, through its operating companies, is the world’s most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 250 Johnson & Johnson operating companies employ approximately 120,500 men and women in 57 countries and sell products throughout the world.
Johnson & Johnson is headquartered in New Brunswick, New Jersey, about 40 miles southwest of New York City.
For further information, please visit www.jnj.com.
